Chronic pain as a manifestation of potassium channel-complex autoimmunity

Neurology

Volumn 79, Issue 11, 2012, Pages 1136-1144

  Klein, Christopher J ^a   Lennon, Vanda A ^a   Aston, Paula A ^a   McKeon, Andrew ^a   Pittock, Sean J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GABAPENTIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN G; METHADONE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OXYCODONE; PREDNISONE; VOLTAGE GATED POTASSIUM CHANNEL;

ADULT; AGED; ANALGESIA; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BURNING SENSATION; CHRONIC PAIN; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; EXCITABILITY; FEMALE; FIBROMYALGIA; FOOT PAIN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERALGESIA; HYPERHIDROSIS; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; NERVE CONDUCTION; NEUROPATHY; NOCICEPTION; PERIPHERAL NERVOUS SYSTEM FUNCTION; PRIORITY JOURNAL; PSYCHOGENIC PAIN; SCORING SYSTEM; SIDE EFFECT; VOLTAGE GATED POTASSIUM CHANNEL COMPLEX AUTOIMMUNE DISEASE; WEIGHT GAIN;

EID: 84867509174     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182698cab     Document Type: Article

References (36)

1. Faber CG, Hoeijmakers JG, Ahn HS, et al. Gain of function Na(V) 1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol 2012;71:26-39.
2. Emery EC, Young GT, Berrocoso EM, Chen L, Mc- Naughton PA. HCN2 ion channels play a central role in inflammatory and neuropathic pain. Science 2011;333: 1462-1466.
3. Takeda M, Tsuboi Y, Kitagawa J, Nakagawa K, Iwata K, Matsumoto S. Potassium channels as a potential therapeutic target for trigeminal neuropathic and inflammatory pain. Mol Pain 2011;7:5.
4. Ocana M, Cendan CM, Cobos EJ, Entrena JM, Baeyens JM. Potassium channels and pain: Present realities and future opportunities. Eur J Pharmacol 2004;500:203-219.
5. Shillito P, Molenaar PC, Vincent A, et al. Acquired neuromyotonia: Evidence for autoantibodies directed against K-channels of peripheral nerves. Ann Neurol 1995;38: 714-722.
6. Hart IK, Waters C, Vincent A, et al. Autoantibodies detected to expressed K-channels are implicated in neuromyotonia. Ann Neurol 1997;41:238-246.
7. Arimura K, Sonoda Y, Watanabe O, et al. Isaacs' syndrome as a potassium channelopathy of the nerve. Muscle Nerve 2002;(suppl 11):S55-S58.
8. Josephs KA, Silber MH, Fealey RD, Nippoldt TB, Auger RG, Vernino S. Neurophysiologic studies in Morvan syndrome. J Clin Neurophysiol 2004;21:440-445.
9. Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 2004;62:1177-1182.
10. Liguori R, Vincent A, Clover L, et al. Morvan's syndrome: Peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 2001;124:2417-2426.
11. Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology 2008;70:1883-1890.
12. McKnight K, Jiang Y, Hart Y, et al. Serum antibodies in epilepsy and seizure-associated disorders. Neurology 2005; 65:1730-1736.
13. Geschwind MD, Tan KM, Lennon VA, et al. Voltagegated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch Neurol 2008;65:1341-1346.
14. Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: A case series. Lancet Neurol 2010;9:776-785.
15. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia Brain 2010;133:2734-2748.
16. Lancaster E, Huijbers MG, Bar V, et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 2011;69:303-311.
17. Traka M, Goutebroze L, Denisenko N, et al. Association of TAG-1 with Caspr2 is essential for the molecular organization of juxtaparanodal regions of myelinated fibers. J Cell Biol 2003;162:1161-1172.
18. Zhou YD, Lee S, Jin Z, Wright M, Smith SE, Anderson MP. Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy. Nat Med 2009;15:1208-1214.
19. International Association for the Study of Pain. Pain definitions: IASP.org: Cited February 2nd 2012; derived from Bonica JJ. The need of a taxonomy. Pain 1979;6:247-248.
20. Dyck PJ, Sherman WR, Hallcher LM, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 1980;8:590-596.
21. Dyck PJ, O'Brien PC, Johnson DM, Klein CJ, Dyck PJ. Quantitative sensation testing. In: Dyck PJ, ed. Peripheral Neuropathy. Philadelphia: Elsevier; 2005:1063-1093.
22. Low PA. Quantitation of autonomic function. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral Neuropathy, 3rd ed. Philadelphia: W.B. Saunders; 1993:729-745.
23. Fealey RD, Low PA, Thomas JE. Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc 1989;64:617-628.
24. Pittock SJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol 2004;56:715-719.
25. Collett B, O'Mahoney S, Schofield P, Closs SJ, Potter J. The assessment of pain in older people. Clin Med 2007;7: 496-500.
26. Kohr D, Singh P, Tschernatsch M, et al. Autoimmunity against the beta(2) adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome. Pain 2011; 152:2690-2700.
27. Arking DE, Cutler DJ, Brune CW, et al. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet 2008;82: 160-164.
28. Bralten LB, Gravendeel AM, Kloosterhof NK, et al. The CASPR2 cell adhesion molecule functions as a tumor suppressor gene in glioma. Oncogene 2010;29:6138-6148.
29. Kalachikov S, Evgrafov O, Ross B, et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet 2002;30:335-341.
30. Silva J, Sharma S, Hughes B, Yu YE, Cowell JK. Homozygous inactivation of the LGI1 gene results in hypomyelination in the peripheral and central nervous systems. J Neurosci Res 2010;88:3328-3336.
31. Woolf CJ. Central sensitization: Implications for the diagnosis and treatment of pain. Pain 2011;152:S2-S15.
32. Alonso-Navarro H, Fernandez-Diaz A, Martin-Prieto M, Ruiz-Ezquerro JJ, Lopez-Alburquerque T, Jimenez- Jimenez FJ. Tremor associated with chronic inflammatory demyelinating peripheral neuropathy: Treatment with pregabalin. Clin Neuropharmacol 2008;31:241-244.
33. Ishii A, Hayashi A, Ohkoshi N, et al. Clinical evaluation of plasma exchange and high dose intravenous immunoglobulin in a patient with Isaacs' syndrome. J Neurol Neurosurg Psychiatry 1994;57:840-842.
34. Newsom-Davis J, Mills KR. Immunological associations of acquired neuromyotonia (Isaacs' syndrome): Report of five cases and literature review. Brain 1993;116: 453-469.
35. Sinha S, Newsom-Davis J, Mills K, Byrne N, Lang B, Vincent A. Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome). Lancet 1991;338:75-77.
36. Vincent A, Irani SR, Lang B. The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins. Curr Opin Neurol 2010;23:144-150.